A Brief Look at SPKL’s Numbers
Here’s last week’s scorecard….the NASDAQ was up 0.14%, the S&P 500 was down 1.08%, and the Dow was down 1.17%. Most of the loss (or near-loss for the NASDAQ) was the result of a weak Thursday and Friday. Those two days unwound Monday’s boost, and were threatening to unwind the surge from the Friday from the week before.
I don’t know what Monday will hold in store; the market has been too erratic to offer any early hints. I still think though (and as I’ve said a few times now) I’m betting against the moves to the edges of the recent boundaries. If we get a gap (bullish or bearish), I’m going to bet the market will move even further in that direction by the end of the day. But, by the end of that day the trend will be exhausted, and we’ll be ripe for a reversal.
So, the most bullish thing we could see for stocks is a much lower open and a big selloff over the course of Monday; by Tuesday AM we’re apt to be rallying again. And, vice versa. I’ll re-insert Saturday’s image of the QQQQ’s, which really illustrates my point.
Monday’ always nutty anyway, so it may be best to be on the sidelines until everyone gets all their anxiety out of their system and into the market. Then when they’re done, we’ll wade in.
By the way, you may have seen Spicy Pickle (SPKL) unveiled their Q4 and full year numbers last week. I have no idea why they don’t put out press releases with their quarterly results - this is the second time they’ve done it. Maybe they don’t think they look all that great, but frankly, they’re actually pretty good for a start-up.
Anyway, I’m not going to examine them as deeply as I normally would. Why? Because they don’t mean much. Spicy Pickle is growing so fast, the year-end data from 12/31/07 is already obsolete. Plus, to compare Q4 from last year to the Q4 from a year ago wouldn’t make much sense, again because they’re growing so fast.
The basic numbers….$1.2 million in revenue, and a net loss of $3.6 million. Pretty much what I expected - going public and doing all that fund-raising can take a toll on the numbers, but it’s mostly a one-time cost. Like I said, comparing now to then (or even comparing now to the future) is not apples to apples.
Anyway, here it is if you want to see the whole filing.
On a semi-related note, a recent reader question got me thinking about Spicy Pickle and how to evaluate it. That’s tough, because the franchise model is unlike any other business. The top line usually looks low. The thing you have to keep in mind is that the bottom lines are generally much bigger (relatively speaking). If there were earnings yet, the price-to-earnings ratio would make the most sense. A price-to-sales ratio means nothing, so don’t bother.
Pick of the Day: Emergent BioSolutions (EBS) is an interesting company….the technicals (chart) caught my eye, but the fundamentals kept my attention. They produce immunobiotics, and apparently good ones. I’m not going to say more, because that’s just not in the scope of the ‘Pick of the Day’. You may want to take a good look though. It’s one of those biotech outfits with current sales as well as potential sales from some projects in the works.
The one thing I’m not crazy about is chasing it after last week’s big runup; I’d like it much better after a good pullback and the establishment of a base.

Are you a subscriber to the Small Cap Network newsletter? If not, you’re missing out on some great trading ideas and exclusive market commentary. To sign up, just go to the top right corner of any page of our website. You’ll be joining thousands of other subscribers who have already benefited from our news and views.



11) Hello. Thank you so much for the stock picks over the last several months. You guys do a great job. I was wondering if you could find out the first couple locations of the kiosks that are going to open up selling the window treatments, etc. I like to see things first hand, and this will allow me to get an early read on the worthiness of this extension. Thank you.




Take a closer look at the chart. That low of $3.00 was also a retest of, and push off of, the 200 day moving average line. We’re back to $3.70 now, and may be on the rise again. The strong peak and sudden selloff may have just been enough to shake off all the nervous-Nellies, leaving behind the serious traders.

So far, Bernanke’s $200 billion purchase of a market recovery reminds me a lot of Evel Knievel’s Snake River Canyon….a brilliant beginning, but quick turn-around into an expensive freefall. It was supposed to be bullish for the market? Since Tuesday’s close, we’re now lower by 2.3%.





After peaking at 22 cents in early February, Applied DNA (